Expression of concern

Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut

Paper Information

Record ID:
61570
Author(s):
Salvatore Cuzzocrea
Barbara Pisano
Laura Dugo
Angela Ianaro
Nimesh S A Patel
Rosanna Di Paola
Tiziana Genovese
Prabal K Chatterjee
Massimo Di Rosa
Achille P Caputi
Christoph Thiemermann
Journal:
British Journal of Pharmacology ( Wiley )
Publication Date:
February 02, 2009
Retraction Date:
December 02, 2024 (<1 year years ago)
Subjects:
Broad Categories:
Biology Biochemistry Toxicology
Institutions:
Countries:
🇮🇹 Italy 🇬🇧 United Kingdom
Article Type:
Research Article
Publisher:
Wiley
Open Access:
Yes
DOI:
10.1038/sj.bjp.0705419
PubMed ID:
12970094
Retraction PubMed ID:
39623604

Expression of concern Details

Retraction Reasons:
Nature of Retraction:

Expression of concern

Retraction Notice:
10.1111/bph.17421
Additional Notes:

see also: https://pubpeer.com/publications/A0E8C439DA8DDEF1CE30EAFDE38931

Citations (99)

99
Total Citations
0
Post-Retraction
99
Pre-Retraction
0
Same Day
Paper citing Rosiglitazone and 15-deoxy-Δ12,14-prostaglandin J2...
Unknown Authors
Unknown Journal
Published: Sep 2008
5936 days before retraction
15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial-monocyte interaction: implication for inflammatory diseases
Ratna Prasad, Shailendra Giri, Avtar Singh et al. (4 authors)
Journal of Inflammation Open Access
Published: Aug 2008
23 citations
5960 days before retraction
7β-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes
Sandrine Le Mée, Olivier Hennebert, Claude Ferrec et al. (5 authors)
Steroids
Published: May 2008
30 citations
6045 days before retraction
Anti-inflammatory effects and changes in prostaglandin patterns induced by 7β-hydroxy-epiandrosterone in rats with colitis
Olivier Hennebert, M.A. Pélissier, Sandrine Le Mée et al. (5 authors)
The Journal of Steroid Biochemistry and Molecular Biology
Published: Apr 2008
42 citations
6069 days before retraction
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia–reperfusion injury in mice with metabolic disorders
Tsuyoshi Honda, Koichi Kaikita, Kenichi Tsujita et al. (10 authors)
Journal of Molecular and Cellular Cardiology
Published: Mar 2008
39 citations
6108 days before retraction
Tissue Repair and Cancer Control through PPARs and Their Coregulators
Liliane Michalik, Walter Wahli
WORLD SCIENTIFIC eBooks
Published: Mar 2008
6120 days before retraction
Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs
Yulan Liu, Jingjing Huang, Yongqing Hou et al. (10 authors)
British Journal Of Nutrition Open Access
Published: Feb 2008
247 citations
6136 days before retraction
Peroxisome proliferator activated receptor γ and oxidized docosahexaenoic acids as new class of ligand
Toshimasa Itoh, Keiko Yamamoto
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Jan 2008
54 citations
6174 days before retraction
ReviewArticle PPARs Mediate Lipid Signaling in Inflammation and Cancer
Liliane Michalik, Walter Wahli
Unknown Journal
Published: Jan 2008
6180 days before retraction
Peroxisome Proliferator-Activated Receptor-γ Ligand, 15-Deoxy-Δ12,14-Prostaglandin J2, Reduces Neutrophil Migration via a Nitric Oxide Pathway
Marcelo Henrique Napimoga, Sílvio M. Vieira, Daniela Dal-Secco et al. (11 authors)
The Journal of Immunology Open Access
Published: Jan 2008
64 citations
6180 days before retraction
PPARs Mediate Lipid Signaling in Inflammation and Cancer
Liliane Michalik, Walter Wahli
PPAR Research Open Access
Published: Jan 2008
105 citations
6180 days before retraction
Importance of peroxisome proliferator-activated receptor-γ in hepatic ischemia/reperfusion injury in mice
Takahiro Akahori, Masayuki Sho, Kaoru Hamada et al. (10 authors)
Journal of Hepatology
Published: Oct 2007
54 citations
6268 days before retraction
Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review
Prabal K. Chatterjee
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Sep 2007
216 citations
6282 days before retraction
ROSIGLITAZONE, AN AGONIST OF PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐GAMMA, PREVENTS CONTRALATERAL TESTICULAR ISCHAEMIA–REPERFUSION INJURY IN PREPUBERTAL RATS
Mustafa İnan, Ümit Nusret Başaran, Dikmen Dökmeci et al. (7 authors)
Clinical and Experimental Pharmacology and Physiology
Published: Apr 2007
13 citations
6445 days before retraction
15-Deoxy-Δ12,14-Prostaglandin J2 Negatively Regulates <i>rankl</i> Gene Expression in Activated T Lymphocytes: Role of NF-κB and Early Growth Response Transcription Factors
Cinzia Fionda, Filomena Nappi, Mario Piccoli et al. (6 authors)
The Journal of Immunology Open Access
Published: Apr 2007
20 citations
6455 days before retraction
Nutrigenomics: Concepts and Applications to Pharmacogenomics and Clinical Medicine
Jim Kaput, Alla Perlina, Betül Hatipoğlu et al. (5 authors)
Pharmacogenomics
Published: Mar 2007
52 citations
6458 days before retraction
Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury
Rosanna Di Paola, Salvatore Cuzzocrea
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Mar 2007
30 citations
6475 days before retraction
PPAR as a new therapeutic target in inflammatory bowel diseases
Laurent Dubuquoy
Gut Open Access
Published: Aug 2006
408 citations
6688 days before retraction
Association between Pro12Ala polymorphism of peroxisome proliferator‐activated receptor‐gamma 2 and myocardial infarction in the Chinese Han population
Lin Li, Longxian Cheng, Ripen Nsenga et al. (5 authors)
Clinical Cardiology Open Access
Published: Jul 2006
34 citations
6729 days before retraction
Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone
Yumin Luo, Wei Yin, Armando P. Signore et al. (8 authors)
Journal of Neurochemistry
Published: Mar 2006
198 citations
6837 days before retraction
Effects of 15-deoxy-Δ12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia
Balázs Hauser, J. Kick, Zsolt Iványi et al. (13 authors)
Intensive Care Medicine
Published: Mar 2006
9 citations
6839 days before retraction
Peroxisome proliferator-activated receptor-γ antagonists GW9662 and T0070907 reduce the protective effects of lipopolysaccharide preconditioning against organ failure caused by endotoxemia*
Marika Collin, Oliver Murch, Christoph Thiemermann
Critical Care Medicine
Published: Mar 2006
26 citations
6842 days before retraction
Involvement of PPAR nuclear receptors in tissue injury and wound repair
Liliane Michalik
Journal of Clinical Investigation Open Access
Published: Mar 2006
227 citations
6851 days before retraction
Rosiglitazone Reduces the Evolution of Experimental Periodontitis in the Rat
Rosanna Di Paola, Emanuela Mazzon, Daniele Maiere et al. (8 authors)
Journal of Dental Research
Published: Feb 2006
49 citations
6879 days before retraction
15-Deoxy-Δ12,14-prostaglandin J2 attenuates development of cyclophosphamide-induced cystitis in rats
Hitoshi Masuda, Michael B. Chancellor, Kazunori Kihara et al. (4 authors)
Urology
Published: Feb 2006
12 citations
6879 days before retraction
Tyrphostin AG 126 reduces intestinal ischemia-reperfusion injury in the rat
Stefania Marzocco, Emanuela Mazzon, Aldo Pinto et al. (5 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Feb 2006
10 citations
6879 days before retraction
ROLE OF ENDOGENOUS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α (PPAR-α) LIGANDS IN THE DEVELOPMENT OF GUT ISCHEMIA AND REPERFUSION IN MICE
Carmelo Muià, Emanuela Mazzon, Concetta Crisafulli et al. (7 authors)
Shock Open Access
Published: Dec 2005
9 citations
6922 days before retraction
Positioning prostanoids of the D and J series in the immunopathogenic scheme
Jason L. Herlong, Thomas R. Scott
Immunology Letters
Published: Nov 2005
91 citations
6967 days before retraction
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor γ, reduces pulmonary inflammatory response in a rat model of endotoxemia
Dan Liu, B. X. Zeng, S. H. Zhang et al. (4 authors)
Inflammation Research
Published: Nov 2005
86 citations
6971 days before retraction
Differential induction of PPAR-γ by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel
Norio Sato, Frederick A. Moore, Bruce C. Kone et al. (9 authors)
AJP Gastrointestinal and Liver Physiology
Published: Oct 2005
69 citations
6976 days before retraction
Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, reduces acute lung injury in endotoxemic rats*
Dong Liu, Bangxiong Zeng, Shihai Zhang et al. (7 authors)
Critical Care Medicine
Published: Oct 2005
75 citations
7002 days before retraction
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARγ
Aní­sio Francisco Soares, Olivier Nosjean, D. Cozzone et al. (10 authors)
Biochemical and Biophysical Research Communications
Published: Sep 2005
40 citations
7010 days before retraction
Protective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non‐diabetic renal diseases
Byung Ha Chung, Sun Woo Lim, Kyung Ohk Ahn et al. (9 authors)
Nephrology
Published: Sep 2005
44 citations
7021 days before retraction
Salutary effects of androstenediol on hepatic function after trauma-hemorrhage are mediated via peroxisome proliferators–activated receptor gamma
Tomoharu Shimizu, L. Szalay, Ya‐Ching Hsieh et al. (6 authors)
Surgery
Published: Aug 2005
16 citations
7063 days before retraction
The selective PPARγ antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion
Massimo Collino, Nimesh S. A. Patel, Kevin M. Lawrence et al. (7 authors)
Kidney International Open Access
Published: Jul 2005
52 citations
7083 days before retraction
The cyclopentenone prostaglandin 15-deoxyΔ12,14-prostaglandin J2 attenuates the development of zymosan-induced shock
Stefania Marzocco, Rosanna Di Paola, Emanuela Mazzon et al. (8 authors)
Intensive Care Medicine
Published: Mar 2005
10 citations
7203 days before retraction
Beneficial effects of PPAR-? ligands in ischemia?reperfusion injury, inflammation and shock
Maha Abdelrahman, Ahila Sivarajah, Christoph Thiemermann
Cardiovascular Research Open Access
Published: Jan 2005
209 citations
7263 days before retraction
Peroxisome proliferator-activated receptor-γ ligands reduce inflammation and infarction size in transient focal ischemia
S. Sundararajan, Jorge Gamboa, Nicole Victor et al. (6 authors)
Neuroscience
Published: Dec 2004
260 citations
7298 days before retraction
A PPAR-<i>γ</i>ligand, 15-deoxy-Δ12,14-prostaglandin J<sub>2</sub>, inhibited gastric mucosal injury induced by ischemia–reperfusion in rats
Tomohisa Takagi, Yuji Naito, Hiroshi Ichikawa et al. (10 authors)
Redox Report
Published: Dec 2004
18 citations
7306 days before retraction
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia–reperfusion damage in rats: role of oxygen free radicals generation
Isabel Villegas, Antonio Ramón Martín, Walber Toma et al. (4 authors)
European Journal of Pharmacology
Published: Nov 2004
95 citations
7336 days before retraction
WY 14643, A POTENT EXOGENOUS PPAR-?? LIGAND, REDUCES INTESTINAL INJURY ASSOCIATED WITH SPLANCHNIC ARTERY OCCLUSION SHOCK
Salvatore Cuzzocrea, Rosanna Di Paola, Emanuela Mazzon et al. (6 authors)
Shock Open Access
Published: Sep 2004
37 citations
7381 days before retraction
Protein Thiol Modification by 15-deoxy-Δ<sup>12,14</sup>-Prostaglandin J<sub>2</sub>Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes
Francisco J. Sánchez-Gómez, Eva Cernuda‐Morollón, Konstantinos Stamatakis et al. (4 authors)
Molecular Pharmacology
Published: Aug 2004
80 citations
7410 days before retraction
Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury
Salvatore Cuzzocrea
Vascular Pharmacology
Published: Jul 2004
45 citations
7459 days before retraction
Ligands of the peroxisome proliferator‐activated receptor‐<i>γ</i> and heart failure
Christoph Thiemermann
British Journal of Pharmacology Open Access
Published: Jul 2004
9 citations
7459 days before retraction
Peroxisome proliferator-activated receptor-γ ligands: A pluripotent class of pharmacological agents that may prove to be useful for adjuvant treatment of sepsis and multiple organ dysfunction syndrome *
Mitchell P. Fink
Critical Care Medicine
Published: Feb 2004
3 citations
7610 days before retraction
Ligands of the peroxisome proliferator‐activated receptor‐<i>γ</i> and heart failure
Christoph Thiemermann
British Journal of Pharmacology Open Access
Published: Jan 2004
16 citations
7641 days before retraction
in mesangial cells: role in the inhibition of pro-inflammatory genes*
Francisco J. Sánchez-Gómez, Eva Cernuda‐Morollón, Konstantinos Stamatakis et al. (4 authors)
Unknown Journal
Published: Jan 2004
7641 days before retraction
The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 ameliorates ischemic acute renal failure
Prabal K. Chatterjee
Cardiovascular Research Open Access
Published: Dec 2003
75 citations
7650 days before retraction
RETRACTED: Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-γ, reduces acute inflammation
Salvatore Cuzzocrea, Maria Barbara Pisano, Laura Dugo et al. (13 authors)
European Journal of Pharmacology
Published: Dec 2003
214 citations
7664 days before retraction
Quick Stats
Total Citations: 99
Years Since Retraction: <1 year
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Effect of ERK inhibitor on corneal neovascularization induc…
European Journal of Inflammation • 0 citations
Methyl helicterilate ameliorates alcohol-induced hepatic fi…
International Immunopharmacology • 13 citations
Curcumin blunts epithelial-mesenchymal transition of hepato…
Redox Biology • 195 citations
Protective effects of fruit extract of Rosa canina and quer…
Food Science & Nutrition • 5 citations
Paris saponin VII enhanced the sensitivity of HepG2/ADR cel…
The Kaohsiung Journal of Medical Sciences • 11 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice